19 June 2013
Keywords: merck, kgaa/kos, niaspan, cleared, eu, germany, kgaa
Article | 02 February 2004
Germany's Merck KGaA and Kos Pharmaceuticals of the USA have reported that Niaspan, an extended-release formulation of niacin, has
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 February 2004
18 June 2013
© 2013 thepharmaletter.com